Stocks and securities in focus
| Security | Change (%) | 1w | 1m | 1y ▼ | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Viking Therapeutics Inc | -4.750% | 22.639% | -1.714% | 285.618% | 326.308% | 1301.128% | - |
| ImmunityBio Inc. | 9.150% | 66.089% | 49.480% | 194.252% | 58.347% | -49.404% | - |
| Ardelyx Inc. | 3.540% | -0.366% | -11.361% | 47.951% | 3.668% | -1.770% | - |
| AnaptysBio Inc | 14.570% | 27.374% | 9.615% | 21.277% | 17.526% | 18.750% | - |
| Voyager Therapeutics Inc | 9.230% | 2.182% | -17.500% | 10.000% | -8.679% | 80.507% | - |
| Cytomx Therapeutics Inc | 170.890% | 0.262% | -23.323% | 3.235% | 9.742% | -80.308% | - |
| Heron Therapeutics Inc. | 2.120% | -16.922% | -15.234% | 0.463% | 38.217% | -85.060% | - |
| Actinium Pharmaceuticals Inc. | 9.810% | 8.939% | -2.177% | -10.125% | 59.071% | 12.344% | - |
| Adaptimmune Therapeutics PLC ADR | -1.800% | 9.901% | -23.973% | -11.905% | 77.600% | -76.282% | - |
| X4 Pharmaceuticals, Inc. | 1.550% | -7.860% | -15.600% | -22.426% | 35.256% | - | - |
| Fate Therapeutics Inc. | 0.510% | -8.103% | -45.632% | -30.166% | 3.965% | -94.909% | - |
| Transgene S.A. | 2.740% | -8.384% | 10.478% | -32.999% | -10.299% | -51.138% | -59.529% |
| Coherus Bioscien. | 5.050% | 2.272% | -12.222% | -70.540% | -36.332% | -84.760% | -86.480% |
| Salarius Pharmaceuticals Inc. | -2.830% | -3.738% | -2.830% | -71.389% | -25.766% | -98.474% | -99.994% |
| Atara Biotherapeutics Inc. | -13.970% | 2.482% | 12.231% | -72.415% | 32.576% | -94.200% | - |
| Brainstorm Cell | 7.270% | -29.447% | -33.143% | -87.283% | 51.293% | -87.897% | - |
| Radius Health Inc. | - | - | - | - | - | - | - |